Business Development Controller

We are looking for a strategic and business-oriented Finance professional to support the Corporate Business Development (BD) organization. The Business Development Controller acts as a Finance business partner, providing critical financial analysis and asset valuation to support key decision-making. The position reports to the Primary Care Corporate Planning and Controlling Manager.

Key Responsibilities
• Deal Modeling & Valuation: Build, refine, and maintain comprehensive financial models (NPV, break-even, scenario analysis, P&L impact) to assess project profitability, asset valuations, and complex deal structures (upfronts, milestones, tiered royalties, COGS).
• Assumption Verification & Due Diligence: Review, challenge, and validate key business drivers, Gross-to-Net dynamics, and investment requirements in alignment with Commercial teams and Regional Hubs/Affiliates.
• Negotiation & Governance Support: Provide Top Management and BD leads with key financial metrics, parameters, and sensitivity analyses to support deal negotiations, internal approval gates, and Board of Directors (BoD) approvals.
• Cross-Functional Finance Alignment: Lead the financial review of draft agreements by coordinating inputs and ensuring alignment across specialized finance functions.
• Post-Investment Reviews: Track and audit the financial performance of newly acquired businesses against the original investment case (look-back analysis).
• Reporting: Prepare high-quality financial presentations and reports for the Executive Committee and Board of Directors.
• Ad-Hoc Initiatives: contributes to varied ad-hoc tasks, financial evaluations, and cross-functional projects as dictated by department operations and leadership priorities. Requirements
•

Education:
Master’s degree in Finance, Economics, or Corporate Strategy.
•

Experience:
5+ years in Corporate Controlling, Corporate Development, or Investment Banking (commercial FP&A experience within the healthcare sector is a strong plus).
• Technical

Skills:
Advanced proficiency in Excel and PowerPoint; hands-on experience with CCH Tagetik is advantageous.
• Financial Acumen: Strong command of financial statements, accounting principles, and corporate valuation methodologies.
• Communication: Full professional fluency in English, with the ability to translate complex financial data into clear, actionable insights for both financial and non-financial stakeholders.
• Mindset & Agility: A sharp analytical and problem-solving approach, paired with the ability to prioritize effectively and deliver high-quality work against tight deadlines in a fast-paced environment. The selected candidate will be employed under Category A in accordance with the provisions of the current National Collective Bargaining Agreement (CCNL) for the Chemical and Pharmaceutical Industry, with an estimated annual base salary between Eur 50.000,00 and Eur 60.000,00, including all applicable contractual and remuneration terms, and in compliance with Legislative Decree No. 96/2026. THE COMPANY Menarini Group is the leading Italian pharmaceutical company with a global presence, recognized worldwide for the quality of its products and services. Its success is built on a long-term strategy focused on Research, Innovation, and Internationalization, combined with a deep commitment to understanding and meeting the evolving needs of physicians and patients. The Group is dedicated to delivering high-quality therapeutic and diagnostic solutions, guided by strong ethical principles, a continuous drive for innovation, a people-centric approach, and a steadfast commitment to environmental sustainability. Collaboration with international partners is one of Menarini Group’s key strengths. By fostering strategic partnerships, the Group creates synergies that drive the development of innovative healthcare solutions, pharmaceutical products, and value-added services. At Menarini, quality is more than a standard. It is the foundation of a shared strategy that guides every aspect of the Group’s operations and supports its mission to improve patients’ lives worldwide.